The 1 hour diabetes test, formally known as the one-hour glucose challenge test (GCT), is one of the most widely administered screening tools in American prenatal care. Nearly every pregnant woman between 24 and 28 weeks of gestation will encounter this test, and understanding what it measures, how to prepare, and what the results mean can significantly reduce anxiety. Unlike the three-hour diagnostic test, the one-hour version does not require fasting and serves purely as an initial screen to identify women who may need further evaluation for gestational diabetes.
The 1 hour diabetes test, formally known as the one-hour glucose challenge test (GCT), is one of the most widely administered screening tools in American prenatal care. Nearly every pregnant woman between 24 and 28 weeks of gestation will encounter this test, and understanding what it measures, how to prepare, and what the results mean can significantly reduce anxiety. Unlike the three-hour diagnostic test, the one-hour version does not require fasting and serves purely as an initial screen to identify women who may need further evaluation for gestational diabetes.
Diabetic ketoacidosis symptoms are among the most serious warning signs in the diabetes spectrum, and understanding them is critical whether you are newly diagnosed or managing a long-standing condition. DKA occurs when the body cannot produce enough insulin and begins breaking down fat for fuel, releasing ketones as a byproduct. Symptoms include fruity-smelling breath, extreme thirst, frequent urination, nausea, vomiting, abdominal pain, and deep labored breathing known as Kussmaul respiration. Recognizing these signs early can be lifesaving, which is why education about all types of diabetes and their complications is so essential.
Understanding the full range of types of diabetes — including Type 1, Type 2, gestational, and rarer forms like LADA and MODY — gives patients and caregivers a clearer picture of how the disease operates across different demographics and physiological contexts. Each type has a distinct cause, progression, and management strategy. The one-hour glucose test is specifically designed to screen for gestational diabetes, but many of the underlying mechanisms it evaluates overlap with risk factors seen in other forms of the disease, making it an excellent entry point for broader diabetes education.
Blood sugar regulation is central to diabetes management regardless of type. In a healthy individual, the pancreas releases insulin after eating, which helps cells absorb glucose from the bloodstream. In someone with impaired glucose tolerance — the state the one-hour test is designed to detect — this process is disrupted. Chronic high blood sugar damages blood vessels, nerves, kidneys, and eyes over time, making early detection and intervention absolutely critical. The one-hour screen exists precisely to catch these impairments before they can cause lasting harm to both mother and baby.
Preparation for the one-hour diabetes test is straightforward compared to many other diagnostic procedures. Patients drink a 50-gram glucose solution — often called Glucola — and then have blood drawn exactly one hour later. No fasting is required beforehand, though some providers recommend avoiding high-sugar foods on the morning of the test to prevent skewing results. A blood glucose reading at or below 140 mg/dL is generally considered passing, though some clinics use a threshold of 130 mg/dL, which increases sensitivity and catches more borderline cases at the cost of more follow-up testing.
If you are studying for a healthcare certification or simply want to deepen your knowledge of diabetes management, including the nuances of screening and diagnosis, you can explore our comprehensive resource on signs of gestational diabetes to understand how the clinical picture develops before and after the one-hour test. Being informed about the full diagnostic pathway — from initial screen to confirmed diagnosis to management planning — empowers patients and future healthcare workers alike to respond effectively when diabetes is suspected or confirmed.
This article covers everything you need to know about the one-hour diabetes test, from how it works to what results mean, alongside key information about diabetic ketoacidosis symptoms, snacks for diabetics, differences between diabetes types, and whether diabetes can be reversed. Whether you are a patient preparing for a prenatal appointment, a nursing student studying metabolic disorders, or a caregiver supporting someone with a recent diagnosis, the information here will give you a strong, evidence-based foundation for navigating the world of diabetes with confidence and clarity.
No fasting required for the one-hour GCT. Most providers recommend arriving hydrated and avoiding an exceptionally high-sugar breakfast. Wear comfortable clothing and plan to stay at the clinic for approximately 90 minutes to allow for check-in, the drink, and the blood draw.
You will be given a 50-gram oral glucose solution, commonly called Glucola, which comes in flavors like orange, lime, and fruit punch. The entire drink must be consumed within five minutes. The liquid is sweet and syrupy; most patients tolerate it well, though some report mild nausea.
After finishing the drink, a one-hour countdown begins. During this time you should remain in or near the clinic. Avoid eating, drinking anything other than water, or engaging in strenuous physical activity, as these can affect how quickly glucose is absorbed and may alter your result.
At the one-hour mark, a phlebotomist draws a small blood sample from a vein in your arm. The sample is sent to a lab where plasma glucose is measured. Results typically return within one to two business days, though some clinics offer same-day results with point-of-care analyzers.
A result at or below 140 mg/dL (or 130 mg/dL depending on your provider's protocol) is considered normal, and no further glucose testing is needed during that pregnancy. A reading above the threshold does not mean you have gestational diabetes — it simply triggers the more definitive three-hour diagnostic test.
If your one-hour result is elevated, your provider will schedule the three-hour oral glucose tolerance test (OGTT), which does require fasting. This test takes multiple blood draws at baseline, one hour, two hours, and three hours, and provides a definitive gestational diabetes diagnosis when two or more values exceed set thresholds.
Understanding the difference between type 1 and type 2 diabetes is essential context for interpreting any diabetes test, including the one-hour glucose challenge. Type 1 diabetes is an autoimmune condition in which the immune system mistakenly destroys the beta cells of the pancreas responsible for producing insulin.
Without insulin, glucose cannot enter cells and accumulates dangerously in the bloodstream. Type 1 accounts for roughly 5 to 10 percent of all diabetes cases and is typically diagnosed in children, teens, and young adults, though it can develop at any age. Management requires daily insulin therapy, careful blood sugar monitoring, and significant lifestyle awareness.
Type 2 diabetes, by contrast, is characterized by insulin resistance — a state in which the body's cells do not respond effectively to insulin even though it is being produced. Over time, the pancreas may also lose its capacity to produce sufficient insulin, compounding the problem. Type 2 is far more common, accounting for 90 to 95 percent of diabetes diagnoses in the United States.
It is strongly associated with excess body weight, physical inactivity, poor dietary habits, and genetic predisposition. Unlike Type 1, Type 2 diabetes often develops gradually and can remain asymptomatic for years before diagnosis. For a deeper comparison, visit our article on the difference between type 1 and type 2 diabetes, which covers diagnostic criteria, risk factors, and management strategies in detail.
Gestational diabetes is a temporary form of the disease that develops during pregnancy in women who did not previously have diabetes. It occurs because pregnancy hormones — particularly human placental lactogen — interfere with insulin signaling, effectively creating insulin resistance. Most cases resolve after delivery, but gestational diabetes significantly increases the mother's lifetime risk of developing Type 2 diabetes — by as much as 50 percent within the following decade. It also raises the risk of complications during pregnancy, including macrosomia (a large baby), preeclampsia, and a higher likelihood of cesarean delivery.
Less commonly discussed but equally important are other forms of diabetes, including Latent Autoimmune Diabetes in Adults (LADA), sometimes called Type 1.5 diabetes, which shares autoimmune features with Type 1 but progresses more slowly and is frequently misdiagnosed as Type 2 in adults. Maturity-Onset Diabetes of the Young (MODY) is a rare genetic form caused by mutations in specific genes that regulate insulin production, and it accounts for approximately one to two percent of diabetes cases. Neonatal diabetes and steroid-induced diabetes round out the spectrum, though these are relatively uncommon in primary care settings.
The signs of gestational diabetes can be subtle and are often absent entirely, which is precisely why the one-hour screening test exists as a universal recommendation for pregnant women. When symptoms do appear, they often mirror those of other types of diabetes: increased thirst, frequent urination, fatigue, and blurred vision. However, many women with gestational diabetes feel entirely normal, making the blood glucose screen indispensable. Elevated fasting blood sugar, glucose in the urine, and a family history of Type 2 diabetes are additional risk markers that prompt earlier or more frequent screening.
Managing blood sugar during pregnancy requires careful attention to both diet and physical activity. Women diagnosed with gestational diabetes are typically counseled by a registered dietitian who helps them develop a meal plan that controls carbohydrate intake without depriving the mother or baby of essential nutrients. Spreading meals across the day, pairing carbohydrates with protein and healthy fats, and monitoring post-meal blood sugar readings are all standard components of gestational diabetes care. In some cases, oral medications such as metformin or insulin injections are necessary when dietary changes alone cannot keep glucose levels within target ranges.
For those managing Type 2 diabetes outside of pregnancy, a broader range of pharmaceutical options exists. Understanding type 2 diabetes medications — from first-line metformin to newer classes like GLP-1 receptor agonists and SGLT-2 inhibitors — is increasingly important as these drugs have shown benefits not just in glucose control but in cardiovascular and renal protection as well. The medication landscape has evolved dramatically over the past decade, giving clinicians and patients more personalized treatment options than ever before.
Diabetic ketoacidosis (DKA) presents with a distinctive cluster of symptoms that worsen rapidly without treatment. The earliest signs are excessive thirst and very frequent urination as the kidneys work to flush excess glucose. This is followed by nausea, vomiting, and abdominal cramping. As ketone levels rise, the breath takes on a fruity or acetone-like odor — a hallmark sign that many first responders are trained to recognize. Fatigue, confusion, and difficulty concentrating reflect the brain's struggle to function without adequate cellular energy. Skin may become dry and flushed.
Advanced DKA produces Kussmaul breathing — rapid, deep, labored respirations — as the body tries to expel carbon dioxide and compensate for metabolic acidosis. Blood pressure may drop, heart rate increases, and the patient can lose consciousness if not treated promptly. Blood glucose in DKA typically exceeds 250 mg/dL, though it can occasionally be lower in so-called euglycemic DKA triggered by certain medications. Urine and blood ketone testing are essential for confirming the diagnosis. Anyone experiencing these symptoms should seek emergency medical care immediately — DKA carries a mortality rate of 1 to 5 percent even with treatment.
DKA occurs most commonly in people with Type 1 diabetes, though it can affect Type 2 patients under conditions of extreme physiological stress. The most frequent triggers are infection (particularly urinary tract infections and pneumonia), missed insulin doses, and new-onset Type 1 diabetes where the disease has not yet been diagnosed. Illness raises levels of stress hormones like cortisol and glucagon that counteract insulin's effects, making glucose control much harder. Surgical procedures, trauma, and myocardial infarction are other recognized precipitants. Some medications, including corticosteroids and certain antipsychotics, can also precipitate DKA.
SGLT-2 inhibitors — a newer class of diabetes medications — have been associated with a rare form of euglycemic DKA in which blood sugar is not dramatically elevated, making the condition harder to recognize. Alcohol abuse, cocaine use, and severe dehydration are additional risk factors. For people managing Type 1 diabetes, consistent insulin use, sick-day management protocols, and regular ketone monitoring are the primary defenses against DKA. Educating patients and families about early warning signs and clear action thresholds is a cornerstone of diabetes care that can prevent the majority of preventable DKA hospitalizations.
When DKA is suspected, the priority is rapid medical evaluation. In a hospital setting, treatment involves intravenous fluids to correct dehydration, insulin infusion to lower blood glucose and suppress ketone production, and careful electrolyte replacement — particularly potassium, which shifts dangerously as treatment proceeds. Bicarbonate therapy may be used in severe acidosis cases. Continuous monitoring of blood glucose, ketones, electrolytes, and acid-base status guides treatment adjustments. Most patients recover within 24 to 48 hours with appropriate care, though underlying triggers like infection must be treated simultaneously to prevent recurrence.
Before reaching the hospital, patients who recognize early DKA symptoms can take limited steps to slow progression. Drinking water helps counteract dehydration, and administering correction insulin (if the patient is conscious, able to swallow, and using an insulin regimen that permits this) may reduce rising glucose. However, self-treatment of suspected DKA is not a substitute for emergency care. Caregivers should call 911 if the patient is vomiting repeatedly, losing consciousness, or breathing abnormally. Sick-day management kits, which include ketone strips and written protocols provided by endocrinologists, help patients act quickly and confidently when glucose levels spike unexpectedly during illness.
Approximately 15 to 23 percent of women fail the one-hour glucose challenge test, but only one-third of those women are ultimately diagnosed with gestational diabetes after the three-hour OGTT. If your one-hour result is elevated, stay calm — your provider is simply following evidence-based protocol to ensure the best outcome for you and your baby. Focus on eating balanced meals, staying hydrated, and attending your follow-up appointment promptly.
Choosing the right snacks for diabetics is one of the most practical and immediately actionable aspects of diabetes self-management. Blood sugar spikes after eating — called postprandial hyperglycemia — are strongly associated with long-term cardiovascular risk, and strategic snacking can help flatten the glucose curve between meals.
The best snacks for people with diabetes are those that combine moderate amounts of complex carbohydrates with protein and healthy fat, since protein and fat slow gastric emptying and blunt the glucose response. Examples include a small apple with almond butter, a hard-boiled egg with a few whole-grain crackers, or a quarter cup of mixed nuts.
Portion control is equally important. Even healthy foods can raise blood sugar significantly when eaten in large amounts, and many popular snack foods marketed as diabetic-friendly still contain enough refined carbohydrates to cause problematic spikes. Reading nutrition labels carefully — particularly the total carbohydrate count and serving size — is a fundamental skill for anyone managing diabetes. A registered dietitian who specializes in diabetes can work with you to identify your personal glucose response to different foods using a food diary paired with blood sugar readings taken one and two hours after eating.
Beyond snacks, the broader concept of a gestational diabetes diet offers useful principles applicable across all types of diabetes. Distributing carbohydrate intake evenly throughout the day — rather than eating most carbs at one or two meals — helps prevent large glucose excursions.
Many clinicians recommend consuming 15 to 30 grams of carbohydrates at each snack and 45 to 60 grams at main meals, though individual needs vary based on weight, activity level, and insulin sensitivity. For evidence-based guidance on meal planning during pregnancy with diabetes, our resource on gestational diabetes diet provides practical meal templates and shopping lists tailored for the prenatal period.
Physical activity is the other major pillar of blood sugar management. Exercise increases cellular sensitivity to insulin, allowing glucose to be taken up from the bloodstream more efficiently even in the absence of medication. Both aerobic exercise (walking, swimming, cycling) and resistance training (weight lifting, bodyweight exercises) have been shown to improve HbA1c levels, reduce insulin requirements in Type 2 diabetes, and lower cardiovascular risk.
For pregnant women with gestational diabetes, walking for 10 to 15 minutes after each meal is one of the most effective strategies for blunting post-meal glucose spikes and has strong evidence supporting its safety in uncomplicated pregnancies.
Stress management is an often overlooked component of diabetes care. Psychological stress triggers the release of cortisol and adrenaline, which raise blood glucose directly and also promote unhealthy eating behaviors. Chronic stress has been linked to worse glycemic control and higher HbA1c in multiple studies. Mindfulness-based stress reduction programs, cognitive behavioral therapy, and even regular moderate exercise have all demonstrated measurable benefits for stress-related glucose dysregulation. Building a support network — whether through a diabetes education class, an online community, or connections with others who have the condition — also contributes meaningfully to long-term self-management success.
The emergence of diabetes-related popular culture, such as the type 1 diabetes Barbie doll introduced by Mattel, reflects growing societal awareness and normalization of the disease. Representation matters — children who see themselves reflected in toys and media develop healthier self-concepts around their conditions, which translates into better adherence and lower rates of diabetes distress. Similarly, diabetes management technology such as continuous glucose monitors, insulin pumps, and the Diabeto app — which connects traditional glucometers to smartphones for logging and trend analysis — are making diabetes self-management more accessible, engaging, and data-driven than ever before.
Footwear is another critical but frequently underemphasized aspect of diabetes care. Diabetic shoes are specially designed with extra depth, wide toe boxes, and seamless interiors to reduce friction and pressure points that can lead to diabetic foot ulcers — a leading cause of lower-limb amputation in the United States.
Medicare covers therapeutic diabetic footwear for beneficiaries who meet clinical criteria, including a documented diagnosis of diabetes with evidence of peripheral neuropathy or poor circulation. Podiatric evaluation and proper footwear selection should be part of the routine care plan for anyone with diabetes lasting more than five years or with known peripheral complications.
The question of whether diabetes can be reversed is one of the most searched and most nuanced in modern endocrinology. The answer depends heavily on which type of diabetes is being discussed. Type 1 diabetes cannot currently be reversed because the autoimmune destruction of beta cells is permanent with existing treatments. Research into beta cell transplantation, immunotherapy, and stem cell approaches holds long-term promise, but these remain experimental. People with Type 1 will require insulin for life based on current medical knowledge, though automated insulin delivery systems are making that life increasingly manageable and safe.
Type 2 diabetes, however, can achieve remission — defined by most major diabetes organizations as an HbA1c below 6.5 percent for at least three months without diabetes medications. Remission is most commonly achieved through significant and sustained weight loss, which directly reduces insulin resistance and can allow remaining beta cells to function adequately.
The landmark DiRECT trial published in The Lancet demonstrated that nearly half of participants who lost 15 kilograms or more achieved remission, with one in four maintaining it at two years. Bariatric surgery produces even more dramatic and durable results, with remission rates exceeding 60 to 80 percent in many studies.
Very low calorie diets (VLCDs) and low-carbohydrate diets have also demonstrated impressive short-term remission rates for Type 2 diabetes, even without the degree of weight loss achieved in surgical interventions. The proposed mechanism involves a reduction in liver fat and pancreatic fat deposits that impair insulin secretion, allowing the pancreas to recover function as those deposits are cleared. It is important to note that remission is not the same as cure — underlying genetic predispositions and metabolic vulnerabilities remain, and weight regain frequently leads to diabetes returning. Lifelong lifestyle vigilance remains essential even after achieving remission.
Gestational diabetes resolves in most women after delivery as pregnancy hormones normalize and insulin sensitivity is restored. However, women who had gestational diabetes should be screened for Type 2 diabetes with a fasting glucose or OGTT at six to twelve weeks postpartum and then every one to three years thereafter, as their lifetime risk of developing Type 2 is substantially elevated.
Breastfeeding has been shown to reduce postpartum glucose levels and may lower the long-term risk of progression to Type 2. Maintaining a healthy weight and active lifestyle after pregnancy are the most evidence-based strategies for preventing the transition from gestational to permanent diabetes.
Insulin resistance, the root driver of Type 2 diabetes and gestational diabetes, is powerfully modifiable through lifestyle. Aerobic exercise improves insulin sensitivity within a single session, and the effect accumulates with regular training. Resistance exercise builds skeletal muscle mass, which serves as a glucose reservoir and improves resting metabolic rate. Dietary patterns rich in fiber, healthy fats, and whole foods — and low in refined carbohydrates, added sugars, and ultra-processed products — consistently produce better glycemic outcomes in clinical trials. These interventions work synergistically and their combined effect often exceeds what any single medication can achieve.
For those who have recently been diagnosed with any form of diabetes, the emotional dimension of the disease is just as important as the clinical management. Diabetes distress — the worry, frustration, and burnout that comes with managing a chronic condition — affects approximately one in four people with diabetes and is strongly associated with worse self-care behaviors and glycemic control. Access to mental health support, diabetes education programs, and peer communities significantly reduces distress and improves outcomes.
The American Diabetes Association, JDRF, and Beyond Type 1 are excellent resources for connecting with support networks, reading the latest research, and finding certified diabetes care and education specialists (CDCES) near you. You can also review our guide on signs of gestational diabetes for additional context on how hormonal and lifestyle factors interact during the critical prenatal screening window.
Looking ahead, the diabetes treatment landscape is being reshaped by breakthroughs in pharmacology, technology, and genetics. Tirzepatide — a dual GIP/GLP-1 receptor agonist — has produced weight loss and glycemic improvements that rival bariatric surgery in clinical trials, and similar agents are in late-stage development. Continuous glucose monitors are becoming smaller, longer-lasting, and more affordable, democratizing real-time glucose data for millions of patients.
Artificial pancreas systems that automatically adjust insulin delivery based on CGM readings are increasingly accessible, dramatically reducing the cognitive burden of Type 1 diabetes management. The future of diabetes care is one of personalization, precision, and genuine hope for outcomes that were unthinkable even a decade ago.
Preparing effectively for any diabetes-related certification exam, nursing school assessment, or patient education program requires more than memorizing definitions — it demands a working understanding of how glucose metabolism functions under normal and pathological conditions, how different interventions affect blood sugar, and how to recognize and respond to acute complications. The one-hour glucose challenge test is a microcosm of this broader knowledge base: it tests glucose clearance, reflects insulin sensitivity, and connects to the entire spectrum of diabetes pathophysiology in a single, elegantly simple clinical procedure.
When studying diabetes content, prioritize understanding the underlying mechanisms rather than surface-level facts. Know why a high-carbohydrate meal spikes blood sugar, how insulin lowers it, what goes wrong in each type of diabetes, and why certain complications — retinopathy, nephropathy, neuropathy, cardiovascular disease — develop over time. Understanding the continuum from insulin resistance to pre-diabetes to Type 2 diabetes helps you anticipate clinical questions about prevention, screening intervals, and management thresholds that commonly appear on nursing and allied health licensure exams.
Practice questions are one of the most effective tools for solidifying clinical diabetes knowledge. Research in cognitive science consistently shows that retrieval practice — actively recalling information through testing — outperforms re-reading or passive review by a significant margin. Using practice tests to identify gaps in your understanding, then returning to targeted study material for those specific gaps, is the most efficient path to exam readiness. Our platform offers multiple sets of Diabetes Blood Sugar Management questions covering the breadth of content you are likely to encounter in formal assessments.
Time management during diabetes-related exams is another critical skill. Many questions on nursing boards and dietetic registration exams are scenario-based, requiring you to synthesize patient history, lab values, and clinical signs into a management decision rather than recall a single isolated fact. Practice reading scenarios at a steady pace, identifying the key clinical question being asked, eliminating distractor answers that are medically plausible but incorrect for the specific scenario, and committing confidently to your final answer. This active, analytical approach to test-taking is a learnable skill that improves significantly with practice.
Familiarize yourself with standard glucose thresholds that appear consistently across board exams and clinical guidelines. A fasting blood glucose of 100 to 125 mg/dL indicates pre-diabetes; 126 mg/dL or higher on two separate occasions confirms diabetes. A two-hour post-OGTT value of 140 to 199 mg/dL indicates impaired glucose tolerance (pre-diabetes), while 200 mg/dL or above indicates diabetes. HbA1c of 5.7 to 6.4 percent represents pre-diabetes, and 6.5 percent or above confirms diabetes. Target HbA1c for most adults with diabetes is below 7 percent, though individualized targets may be higher or lower based on age, comorbidities, and risk of hypoglycemia.
For candidates studying pharmacology in the context of diabetes, it is worth understanding the mechanisms, benefits, and adverse effects of the major drug classes. Metformin works by reducing hepatic glucose production and improving insulin sensitivity; it is the first-line medication for most people with Type 2 diabetes. Sulfonylureas stimulate insulin secretion but carry a risk of hypoglycemia and weight gain.
GLP-1 receptor agonists promote insulin release, suppress glucagon, delay gastric emptying, and produce significant weight loss — making them increasingly preferred agents in people with obesity and cardiovascular disease. SGLT-2 inhibitors lower blood sugar by causing the kidneys to excrete glucose in the urine, and they have demonstrated remarkable cardioprotective and nephroprotective effects independent of their glucose-lowering action.
Finally, cultivate a patient-centered mindset in all your diabetes education and clinical practice. Diabetes management is not a failure of willpower when it proves difficult — it is the daily management of a complex, metabolically demanding condition that is influenced by sleep, stress, hormones, medications, illness, and dozens of other variables outside any individual's full control.
Effective diabetes care requires empathy, cultural humility, and a genuine commitment to meeting patients where they are. Whether you are a student preparing for licensure, a clinician refreshing your knowledge, or a patient trying to understand your own diagnosis, that human-centered perspective is the foundation on which all excellent diabetes care is built.